SCHEMBL4254994

SCHEMBL4254994

SCCNC(c1ccccc1)(c1ccccc1)c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.44
KIF11 P52732 2/20 0.44
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
OPRK1 P41145 2/20 0.41
KCNH2 Q12809 2/20 0.41
ADRA1A P35348 1/20 0.41
KCNA3 P22001 2/20 0.36
TSHR P16473 2/20 0.35
CYP3A4 P08684 2/20 0.35
MEN1 O00255 1/20 0.35
SLC22A1 O15245 1/20 0.35
NR1I2 O75469 1/20 0.35
GMNN O75496 1/20 0.35
USP2 O75604 1/20 0.35
TRPM2 O94759 1/20 0.35
ABCB11 O95342 1/20 0.35
EGFR P00533 1/20 0.35
CA2 P00918 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12264150 0.90 KCNN4 (0.50) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL12264151 0.86 KCNN4 (0.47) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL319646 0.82 KIF11 (0.63) KCNN4KIF11TSHRIDO1DUT
SCHEMBL14156837 0.77 HTR2A (0.40) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL2223266 0.77 KCNN4 (0.44) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL17929547 0.76 KIF11 (0.57) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL14156834 0.73 KIF11 (0.36) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL29262767 0.73 KCNN4 (0.61) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL191706 0.73 KCNN4 (0.52) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL2273209 0.73 KCNN4 (0.57) KCNN4KIF11HTR2AHTR2COPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318454-A1 NOVEL ANTIOXIDANTS AND METHODS OF TREATMENT WEINER, CARL P 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318454-A1 NOVEL ANTIOXIDANTS AND METHODS OF TREATMENT GPX1, SOD1, GPX4 KCNN4 2822/4885KIF11 4606/4885HTR2A 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.